Characteristics and Outcomes of Newly Diagnosed Multiple Myeloma Patients, Including High-Risk Cytogenetic and African-American Subgroups, Treated with Daratumumab-based Frontline Regimens in Real-world

AMERICAN JOURNAL OF HEMATOLOGY(2023)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要